Results 131 to 140 of about 10,476 (150)

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Nature, 2022
Ağan H ŞEkercioğlu, Andrew Mcquillin, Antonio F Pardiñas   +2 more
exaly  

Rare coding variants in ten genes confer substantial risk for schizophrenia

Nature, 2022
Gill Livingston, Tarjinder Singh, David Curtis   +2 more
exaly  

Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study

Psychological Medicine, 2020
Robyn E Wootton, Rebecca C Richmond, Bobby Stuijfzand   +2 more
exaly  

Altering the course of schizophrenia: progress and perspectives

Nature Reviews Drug Discovery, 2016
Annie Andrieux, Kristin S Cadenhead, Paola Dazzan   +2 more
exaly  

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

Nature, 2009
Naomi R Wray, Peter M Visscher, Patrick F Sullivan   +2 more
exaly  

Neurophysiological biomarkers for drug development in schizophrenia

Nature Reviews Drug Discovery, 2008
Daniel C Javitt, Kevin M Spencer, Mihály Hajós   +2 more
exaly  

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

World Psychiatry, 2020
John H Krystal, Oliver D Howes, Robert A Mccutcheon   +2 more
exaly  

Schizophrenia risk from complex variation of complement component 4

Nature, 2016
Nolan Kamitaki, Vanessa E Van Doren, Giulio Genovese   +2 more
exaly  

Nonsocial and social cognition in schizophrenia: current evidence and future directions

World Psychiatry, 2019
Michael F Green, Junghee Lee
exaly  

Common variants conferring risk of schizophrenia

Nature, 2009
Hreinn Stefansson, Stacy Steinberg, Srdjan Djurovic   +2 more
exaly